Physician profile

Roberto Rene Gonzalez

Gastroenterology (Internal Medicine) · Miami, FL

NPI 1326205774

$30,391.13

in general payments reported to CMS, 2019-2025

28 companies · $205 in 2025

The $205 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

See the full distribution for Gastroenterology (Internal Medicine)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,802.93
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$1,700.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $27,189.10 2019-2025 Exalt Model D, Spyscope Ds, Acquire
Pentax of America, INC. $655.56 2019-2024 Pentax Medical, Inspira, C2 Cryoballoon Focal Controller
Abbvie INC. $527.55 2019-2024
Medtronic, INC. $317.37 2021-2022
Janssen Scientific Affairs, LLC $242.18 2019-2020
Fujifilm Healthcare Americas Corporation $225.04 2023 Fujifilm
Madrigal Pharmaceuticals $154.85 2024-2025 Rezdiffra, Resmetirom
Phathom Pharmaceuticals, INC. $133.42 2024 Voquezna
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $129.90 2019-2023 Xifaxan
Merck Sharp & Dohme LLC $117.77 2019
Takeda Pharmaceuticals U.S.A., INC. $102.37 2019
Covidien LP $92.19 2019
Ethicon US, LLC $86.91 2019
Daiichi Sankyo INC. $66.87 2019-2020
Janssen Biotech, INC. $61.93 2022-2024 Tremfya, Stelara
Show all 28 companies
CompanyGeneral paymentsYearsTop products
Redhill Biopharma INC. $39.81 2021
Intercept Pharmaceuticals, INC. $38.78 2022-2023 Ocaliva
Alfasigma USA, INC. $34.12 2020
Ferring Pharmaceuticals INC. $33.29 2024 Rebyota
Allergan, INC. $20.38 2020
Shire North American Group INC $17.66 2019
Glaxosmithkline, LLC. $17.49 2019
Qol Medical, LLC $16.67 2024 Sucraid
Ardelyx, INC. $16.65 2024 Ibsrela
Endo Pharmaceuticals INC. $14.39 2020
Braintree Laboratories, INC. $13.20 2019
Pfizer INC. $13.16 2019
Genzyme Corporation $12.52 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Roberto Rene Gonzalez

$30,391.13

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $205 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

https://glasscript.com/doctor/60714/roberto-rene-gonzalez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.